| Schedule of Disaggregation of Revenue |
The following table presents the Company’s revenue disaggregated by geographic areas based on the customers’ locations: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Six Months Ended | | (in thousands) | June 30,
2026 | | June 30,
2025 | | June 30,
2026 | | June 30,
2025 | | United States | | | | | | | | | Screening | $ | 41,447 | | | $ | 34,208 | | | $ | 80,173 | | | $ | 62,912 | | | Development Services | 200 | | | — | | | 200 | | | 255 | | International(1) | | | | | | | | | Screening | 1,195 | | | 171 | | | 2,301 | | | 600 | | | Development Services | 1,845 | | | 1,165 | | | 2,798 | | | 3,614 | | | Total | $ | 44,687 | | | $ | 35,544 | | | $ | 85,472 | | | $ | 67,381 | |
(1) International region includes revenue earned from customers located outside of the United States.The following table presents the Company’s revenue disaggregated by revenue source: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Six Months Ended | | (in thousands) | June 30,
2026 | | June 30,
2025 | | June 30,
2026 | | June 30,
2025 | | Screening | | | | | | | | | Commercial | $ | 39,784 | | | $ | 33,472 | | | $ | 77,449 | | | $ | 62,253 | | Government(1) | 2,858 | | | 907 | | | 5,025 | | | 1,259 | | | Development Services | | | | | | | | | Commercial | 2,045 | | | 1,165 | | | 2,998 | | | 3,869 | | | | | | | | | | | Total | $ | 44,687 | | | $ | 35,544 | | | $ | 85,472 | | | $ | 67,381 | |
(1) Government screening revenue primarily consists of revenue earned as part of our Galleri-Medicare clinical study.
|